MNDL Bio
Optimization of Gene Expression using Computational Approaches
Company Overview
Snapshot
Founded in June 2023 by Steve Grun, Eran Miller, and Tamir Tuller, MNDL Bio operates with 1–10 employees. The company has raised a total of $2.1 million across two funding rounds. In January 2024, MNDL Bio secured Pre-Seed funding from Earth & Beyond Ventures.
Business overview
MNDL Bio specializes in optimizing gene expression within cells to enhance protein production yields. The company leverages advanced algorithms, patented methods, Artificial Intelligence (AI), and Machine Learning (ML) based on genomic Big Data. MNDL Bio's technology improves the efficiency and cost-effectiveness of biological systems, with applications across various sectors including alternative protein sources, precision fermentation for sustainable biofuels, and bio-based materials like bioplastics. The company operates within the Health Tech & Life Sciences sector, with relevance to Climate Tech.
Strategic signal
MNDL Bio's recognition in the Middle East, winning an award for the most innovative biotech solution in March 2025, highlights its emerging leadership and validates its AI-powered gene optimization platform. This signal suggests strong regional market acceptance and potential for broader strategic partnerships, positioning the company as a key innovator in the biotechnology landscape.
Log in to access full profile ›Company Intelligence Q&A
- What is MNDL Bio's core technology?
- MNDL Bio utilizes Artificial Intelligence (AI) and Machine Learning (ML) based on genomic Big Data, employing advanced algorithms and patented methods to optimize gene expression in cells, thereby increasing protein production yield.
- When was MNDL Bio founded and by whom?
- MNDL Bio was founded in June 2023 by Steve Grun, Eran Miller, and Tamir Tuller.
- What was a significant recent achievement for MNDL Bio?
- In March 2025, MNDL Bio won an award for the most innovative biotech solution in the Middle East, recognizing its contributions to the sector.
- Which accelerator program did MNDL Bio participate in?
- In April 2025, MNDL Bio participated in the Intel-backed Ignite startup program in Israel, which kicked off its first cohort.
- What is MNDL Bio's relevance to climate tech?
- MNDL Bio's solutions contribute to climate tech by facilitating cost-effective production of alternative protein sources, enhancing precision fermentation for sustainable biofuels, and enabling the creation of bio-based materials like bioplastics, all of which aim to reduce greenhouse gas emissions and promote environmental sustainability.